Detalhe da pesquisa
1.
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Cancer
; 130(6): 876-885, 2024 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985359
2.
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood
; 140(5): 504-515, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512184
3.
The oncologic burden of hepatitis C virus infection: A clinical perspective.
CA Cancer J Clin
; 67(5): 411-431, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28683174
4.
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Blood
; 137(23): 3272-3276, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534891
5.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074072
6.
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma.
Haematologica
; 106(10): 2667-2672, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732355
7.
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
Support Care Cancer
; 29(1): 97-105, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314052
8.
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Haematologica
; 105(7): 1907-1913, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601688
9.
Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients.
Hematol Oncol
; 38(3): 301-308, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196714
10.
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Am J Hematol
; 95(6): 623-629, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239765
11.
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Br J Haematol
; 185(5): 874-882, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919940
12.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol
; 185(4): 670-678, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30820940
13.
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Am J Gastroenterol
; 114(2): 250-257, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410039
14.
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 130(4): 472-477, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522441
15.
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
Ophthalmic Plast Reconstr Surg
; 35(3): 243-246, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124609
16.
Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.
Int J Cancer
; 142(5): 940-948, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047108
17.
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Cancer
; 124(12): 2561-2569, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723393
18.
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Br J Haematol
; 182(3): 404-411, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785709
19.
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Blood
; 137(8): 1124-1129, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32932518
20.
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Lancet Oncol
; 18(1): 100-111, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923552